This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Buck Institute for Research on Aging, University of California. Active years: 1994-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 51 
2 out of 16,025 
Years Active: 1994-2026
Title: Innovations and Contributions of Gary K. Scott
Introduction
Gary K. Scott is a notable inventor based in Berkeley, CA, who has made significant contributions to the field of cancer research. With a total of 4 patents, his work focuses on innovative therapeutic applications aimed at treating cancer through novel biochemical methods.
Latest Patents
One of Gary K. Scott's latest patents is titled "Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications." This invention provides a cancer treatment method based on the inhibition of proline catabolism. When combined with p53 restoration therapy and/or inhibition of glutaminase, this approach results in a 'synthetic lethal' and synergistic anticancer response. Additionally, the patent introduces novel suicide inhibitors that induce the degradation of proline dehydrogenase (PRODH). It also includes a method for assaying PRODH to identify responders and non-responders to the inhibition of proline catabolism and/or glutaminase.
Another significant patent is "ETS-related gene overexpressed in human breast and epithelial cancers." This invention presents a cDNA that is a coding region of a previously unknown member of the ETS transcription regulator family. The gene, designated ESX, is located at chromosome 1q32, a region amplified in 50% of early breast cancers. The ESX gene is associated with the etiology of various cancers, including breast cancers, making its detection of diagnostic and prognostic value.
Career Highlights
Gary K. Scott has worked with prestigious institutions such as the University of California and the Buck Institute for Research on Aging. His research has significantly advanced the understanding of cancer biology and therapeutic strategies.
Collaborations
Throughout his career, Gary has collaborated with esteemed colleagues, including Christopher C. Benz and Chuan-Hsiung Chang. These collaborations have further enriched his research and contributed to the development of innovative cancer treatments.
Conclusion
In summary, Gary K. Scott is a prominent inventor whose work in cancer research has led to valuable patents and collaborations. His innovative approaches to treatment continue to impact the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile